InvestorsHub Logo

sumbuysumsell

04/13/24 9:31 AM

#456536 RE: Steady_T #456530

Any change in in CEO is not going to have a short term improvement.


So you are saying there is a chance a new CEO would bring a long term improvement? Who here is in for the short term?
IMO the present CEO has lost too much street credibility with his shenanigans.... There are too many shareholders that are simply PO'ed at being manipulated and ignored.

BIOChecker4

04/13/24 12:43 PM

#456546 RE: Steady_T #456530

I’ll add this excuse to my list.

If Anavex were to bring on an experienced CEO with a track record of success and the respect of pharma and big institutional biotech investors, the stock would react positively.

I’ll never understand why shareholders feel the need to defend this guy when all he has done is cost them dearly except that they have a vested interest in never admitting to being wrong.

Loyalty to Missling has been a sure way to lose your shirt even as he has enriched himself at shareholders’ expense.